Drug treatment for chronic systolic heart failure

Thoracic and Cardiovascular Surgeon, Supplement

Volumn 58, Issue SUPPL. 2, 2010, Pages

  Morike K ^a   Sindermann, J R ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Chronic heart failure; Drug treatment; Medical therapy

Indexed keywords

AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CLARITHROMYCIN; CYCLOSPORIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROMYCIN; ITRACONAZOLE; METOPROLOL SUCCINATE; QUINIDINE; VERAPAMIL;

ANGIONEUROTIC EDEMA; ANOREXIA; BRADYCARDIA; BREAST TENDERNESS; CARDIOVASCULAR RISK; CLINICAL TRIAL; COUGHING; DIABETES MELLITUS; DIGITALIS INTOXICATION; DISORIENTATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FLUID RETENTION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; NAUSEA AND VOMITING; PRIORITY JOURNAL; SHORT SURVEY; SIDE EFFECT; SUSTAINED DRUG RELEASE; SYSTOLIC HEART FAILURE; UREMIA; VISUAL DISORDER; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; DIGITALIS GLYCOSIDES; DIURETICS; HEART FAILURE, SYSTOLIC; TREATMENT OUTCOME;

EID: 76149133687     PISSN: 09464778     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1240711     Document Type: Short Survey

References (6)

1. Hunt S A., Abraham W T., Chin M H., Feldman A M., Francis G S., Ganiats T G., Jessup M, Konstam M A., Mancini D M., Michl K, Oates J A., Rahko P S., Silver M A., Stevenson L W., Yancy C W., American College of Cardiology Foundation American Heart Association. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults. A report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol 2009 53 e1-e90
2. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray J J., Ponikowski P, Poole-Wilson P A., Strömberg A, van Veldhuisen D J., Atar D, Hoes A W., Keren A, Mebazaa A, Nieminen M, Priori S G., Swedberg K, ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen S D., McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano J L. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur Heart J 2008 29 2388-2442
3. Arzneimittelkommission der deutschen rzteschaft. Empfehlungen zur Therapie der chronischen Herzinsuffizienz. 3rdedition. Arzneiverordnungen in der Praxis 2007 34 http://www.akdae.de
4. Brown N J., Byiers S, Carr D, Maldonado M, Winter B A. Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 2009 54 516-523
5. Krum H, Abraham W T. Heart failure. Lancet 2009 373 941-955
6. Slørdal L, Spigset O. Heart failure induced by non-cardiac drugs. Drug Saf 2006 29 567-586